↓ Skip to main content

Dove Medical Press

Safety and tolerability of switching to asenapine from other antipsychotic agents: pooled results from two randomized multicenter trials in stable patients with persistent negative symptoms in…

Overview of attention for article published in Neuropsychiatric Disease and Treatment, June 2012
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (70th percentile)
  • Good Attention Score compared to outputs of the same age and source (68th percentile)

Mentioned by

patent
5 patents
peer_reviews
1 peer review site

Citations

dimensions_citation
14 Dimensions

Readers on

mendeley
67 Mendeley
Title
Safety and tolerability of switching to asenapine from other antipsychotic agents: pooled results from two randomized multicenter trials in stable patients with persistent negative symptoms in schizophrenia
Published in
Neuropsychiatric Disease and Treatment, June 2012
DOI 10.2147/ndt.s29891
Pubmed ID
Authors

Karen Pemberton, Pilar Cazorla, Armin Szegedi, Xianwei Ha, Jun Zhao, Mary Mackle

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 67 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 1%
Canada 1 1%
Unknown 65 97%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 11 16%
Researcher 10 15%
Student > Master 9 13%
Other 8 12%
Student > Ph. D. Student 7 10%
Other 9 13%
Unknown 13 19%
Readers by discipline Count As %
Medicine and Dentistry 17 25%
Pharmacology, Toxicology and Pharmaceutical Science 10 15%
Psychology 9 13%
Biochemistry, Genetics and Molecular Biology 5 7%
Neuroscience 3 4%
Other 8 12%
Unknown 15 22%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 May 2023.
All research outputs
#7,355,485
of 25,373,627 outputs
Outputs from Neuropsychiatric Disease and Treatment
#948
of 3,132 outputs
Outputs of similar age
#49,872
of 179,218 outputs
Outputs of similar age from Neuropsychiatric Disease and Treatment
#5
of 16 outputs
Altmetric has tracked 25,373,627 research outputs across all sources so far. This one has received more attention than most of these and is in the 69th percentile.
So far Altmetric has tracked 3,132 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.6. This one has gotten more attention than average, scoring higher than 68% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 179,218 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.
We're also able to compare this research output to 16 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 68% of its contemporaries.